Comparison of Time to Extubation Using Sugammadex or Neostigmine

• Status: Not yet recruiting
• Trial end date: 2022-12-30
• Target enrollment: 0
• Participant gender: All

Summary

A prospective blinded randomized clinical trial to compare time to extubation using Sugammadex versus Neostigmine/glycopyrrolate as reversal agents after use of neuromuscular blockade agents in an outpatient bronchoscopy suite.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Temple University
• Collaborator: Merck Sharp & Dohme Corp.
• Treatments: Glycopyrrolate; Neostigmine

Criteria

Inclusion Criteria:

1. has diagnosis of COPD or ILD

2. ASA 3 or 4

3. procedure requires general anesthesia in the outpatient bronchoscopy suite

4. glomerular filtration rate > 30 ml/min

Exclusion Criteria:

1. pregnant women

2. prisoners

3. those unable to consent for themselves

4. procedures not requiring general anesthesia

5. ASA 1 or 2